Ticker | Name | Market cap, $ | Price, $ | Price change, %today | Country | PE ratio | PB ratio | PS ratio | Revenue (quarterly), $ | EPS diluted (quarterly), $ |
|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | 118.95 B | 461.89 | 0.00 | United States | 7.61 | 11.19 | 2.77 B | 4.01 | ||
| Regeneron Pharmaceuticals | 82.42 B | 750.02 | +0.80 | United States | 18.56 | 2.81 | 5.95 | 3.72 B | 11.54 | |
| argenx SE | 35.39 B | 591.82 | 0.00 | Netherlands | 19.04 | 573.24 M | 1.39 | |||
| Alnylam Pharmaceuticals | 32.11 B | 248.99 | +0.31 | United States | 992.61 | 15.33 | 500.92 M | -0.87 | ||
| BioNTech SE | 24.56 B | 102.45 | -4.70 | Germany | 1.15 | 7.43 | 1.37 B | 0.89 | ||
| BeiGene | 20.58 B | 193.00 | -1.53 | Cayman Islands | 5.99 | 6.20 | 1.00 B | -1.17 | ||
| United Therapeutics | 16.08 B | 360.20 | -1.13 | United States | 15.82 | 2.64 | 5.83 | 748.90 M | 6.39 | |
| Moderna | 14.17 B | 36.81 | -0.24 | United States | 1.19 | 2.80 | 1.85 B | 0.03 | ||
| Summit Therapeutics | 14.00 B | 18.99 | 0.00 | United States | 31.98 | -0.08 | ||||
| Incyte | 13.69 B | 71.05 | 0.00 | United States | 507.50 | 4.32 | 3.36 | 1.14 B | 0.54 | |
| Genmab A/S | 13.18 B | 20.75 | 0.00 | Denmark | 19.72 | 2.76 | 4.57 | 816.44 M | 0.29 | |
| Insmed Incorporated | 13.00 B | 72.67 | 0.00 | United States | 26.89 | 37.91 | 93.42 M | -1.27 | ||
| BioMarin Pharmaceutical | 11.92 B | 62.56 | 0.00 | United States | 37.46 | 2.20 | 4.33 | 745.74 M | 0.55 | |
| Royalty Pharma | 11.68 B | 26.29 | 0.00 | United States | 10.31 | 1.70 | 5.15 | 564.69 M | 1.21 | |
| Bio-Techne | 11.14 B | 70.11 | 0.00 | United States | 74.59 | 5.21 | 9.51 | 289.46 M | 0.21 | |
Ticker | Name | Market cap, $ | Price, $ | Price change, %today | Country | PE ratio | PB ratio | PS ratio | Revenue (quarterly), $ | EPS diluted (quarterly), $ |
On page:
On page: